Keyphrases
Nephropathy
100%
Type 1 Diabetic Patient
100%
Diabetic Nephropathy
100%
Improved Prognosis
100%
Prospective Follow-up
100%
End-stage Renal Disease
50%
Median Survival Time
33%
Antihypertensive Treatment
33%
Cardiovascular Mortality
16%
Systolic Blood Pressure
16%
Confidence Interval
16%
Hazard Ratio
16%
Cause of Death
16%
Glycemic Control
16%
All-cause Mortality
16%
Cardiovascular Morbidity
16%
Statins
16%
Aspirin
16%
Log-rank Test
16%
Renoprotective Effect
16%
Patient Survival
16%
Normoalbuminuria
16%
Protective Treatment
16%
Cardiovascular Protective
16%
Medicine and Dentistry
Nephropathy
100%
Diabetes Mellitus
100%
Diabetic Nephropathy
100%
End Stage Renal Disease
50%
Cardiovascular System
33%
Antihypertensive Therapy
33%
Median Survival Time
33%
Systolic Blood Pressure
16%
Hazard Ratio
16%
Acetylsalicylic Acid
16%
All Cause Mortality
16%
Log Rank Test
16%
Glycemic Control
16%
Statin
16%
Cardiovascular Mortality
16%
Pharmacology, Toxicology and Pharmaceutical Science
Diabetes Mellitus
100%
Kidney Disease
100%
Diabetic Nephropathy
100%
End Stage Renal Disease
50%
Antihypertensive Agent
33%
Median Survival Time
33%
All Cause Mortality
16%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
16%
Cardiovascular Mortality
16%
Acetylsalicylic Acid
16%